{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:33:24Z","timestamp":1770888804725,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.urology.2007.10.023","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T09:55:49Z","timestamp":1205488549000},"page":"460-464","source":"Crossref","is-referenced-by-count":16,"title":["Role of Trospium Chloride in Brachytherapy-Related Detrusor Overactivity"],"prefix":"10.1016","volume":"71","author":[{"given":"Nathan","family":"Bittner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Brammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Niehaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent E.","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachariah A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Galbreath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.10.023_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2004.09.036","article-title":"Prophylactic tamulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study","volume":"62","author":"Elshaikh","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2007.10.023_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0090-4295(02)01840-X","article-title":"Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy","volume":"60","author":"Merrick","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.10.023_bib3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1464-410X.2006.06491.x","article-title":"The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer","volume":"98","author":"Blaivas","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2007.10.023_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.10.023_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000173630.94559.fd","volume":"174","author":"Lee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.10.023_bib6","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.10.023_bib7","first-page":"525","article-title":"A comparative study of the efficacy and safety of tamulosin hydrochloride alone and combination of propiverine hydrochloride and tamulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and\/or urinary incontinence","volume":"12","author":"Saitoh","year":"1999","journal-title":"Jap J Urol Surg"},{"key":"10.1016\/j.urology.2007.10.023_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000282787","article-title":"Flavoxate treatment of micturition disorders accompanying benign prostatic hypertrophy: a double-blind placebo-controlled multicenter investigation","volume":"55","author":"Dahm","year":"1995","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2007.10.023_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2007.10.023_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ucl.2006.06.006","article-title":"Trospium chloride: distinct among other anticholinergic agents available for the treatment of overactive bladder","volume":"33","author":"Statskin","year":"2006","journal-title":"Urol Clin N Am"},{"key":"10.1016\/j.urology.2007.10.023_bib11","first-page":"78","article-title":"Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation","volume":"6","author":"Merrick","year":"2000","journal-title":"Tech Urol"},{"key":"10.1016\/j.urology.2007.10.023_bib12","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1097\/01.coc.0000091297.21810.fa","article-title":"Extracapsular radiation dose distribution following permanent prostate brachytherapy","volume":"26","author":"Merrick","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.urology.2007.10.023_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.urology.2007.10.023_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0360-3016(99)00405-8","article-title":"Seed fixity in the prostate\/periprostatic region following brachytherapy","volume":"46","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2007.10.023_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11934-002-0095-3","article-title":"Overactive bladder in the male patient: bladder, outlet, or both?","volume":"3","author":"Abdel-Aziz","year":"2002","journal-title":"Curr Urol Rep"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950702273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950702273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T21:23:07Z","timestamp":1546204987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042950702273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S009042950702273X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.10.023","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}